Ledger.Open graph →
SEC Form D · filed October 15, 2025

Belhaven Biopharma Inc

Offering
$32.3M
Sold
$32.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Chapel Hill, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

David A. Neal · Chapel Hill, NCExec · DirectorDerek A. Winstanly · Chapel Hill, NCDirectorWes A. Wheeler · Chapel Hill, NCDirectorScott D. Lyman · Chapel Hill, NCExec · DirectorWes A. Wheeler · Chapel Hill, NCDirectorDerek A. Winstanly · Chapel Hill, NCDirectorScott D. Lyman · Chapel Hill, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗